Published in Medicine (Baltimore) on November 01, 2015
CT Coronary Angiography and Computational Fluid Dynamics | NCT01189331
Diagnostic performance of instantaneous wave-free ratio for the evaluation of coronary stenosis severity confirmed by fractional flow reserve: A PRISMA-compliant meta-analysis of randomized studies. Medicine (Baltimore) (2016) 0.78
Noninvasive fractional flow reserve derived from coronary computed tomography angiography for identification of ischemic lesions: a systematic review and meta-analysis. Sci Rep (2016) 0.75
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med (2009) 13.42
Diagnostic tests. 1: Sensitivity and specificity. BMJ (1994) 11.35
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med (2012) 8.39
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol (2011) 6.35
Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol (2014) 3.47
SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr (2009) 3.22
Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation (2001) 3.03
Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography. Circulation (2001) 2.01
Patient-specific modeling of blood flow and pressure in human coronary arteries. Ann Biomed Eng (2010) 1.83
Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur Heart J (2013) 1.76
Assessment of intermediate severity coronary lesions in the catheterization laboratory. J Am Coll Cardiol (2007) 1.68
The emerging role of cardiac computed tomography for the assessment of coronary perfusion: a systematic review and meta-analysis. Can J Cardiol (2012) 1.51
Effect of image quality on diagnostic accuracy of noninvasive fractional flow reserve: results from the prospective multicenter international DISCOVER-FLOW study. J Cardiovasc Comput Tomogr (2012) 1.29
Usefulness of noninvasive fractional flow reserve computed from coronary computed tomographic angiograms for intermediate stenoses confirmed by quantitative coronary angiography. Am J Cardiol (2012) 1.24
Rationale and design of the DeFACTO (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiOgraphy) study. J Cardiovasc Comput Tomogr (2011) 1.23
Diagnostic-therapeutic cascade revisited: coronary angiography, coronary artery bypass graft surgery, and percutaneous coronary intervention in the modern era. Circulation (2008) 1.21
A novel noninvasive technology for treatment planning using virtual coronary stenting and computed tomography-derived computed fractional flow reserve. JACC Cardiovasc Interv (2013) 1.13
Clinical expert consensus statement on best practices in the cardiac catheterization laboratory: Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv (2012) 1.11
Use of fractional myocardial flow reserve to assess the functional significance of intermediate coronary stenoses. Am J Cardiol (2000) 1.05
CT angiography (CTA) and diagnostic performance of noninvasive fractional flow reserve: results from the Determination of Fractional Flow Reserve by Anatomic CTA (DeFACTO) study. AJR Am J Roentgenol (2014) 0.97
Incorporating autoregulatory mechanisms of the cardiovascular system in three-dimensional finite element models of arterial blood flow. Ann Biomed Eng (2010) 0.96
CT fractional flow reserve: the next level in non-invasive cardiac imaging. Neth Heart J (2012) 0.96
Rationale and design of the HeartFlowNXT (HeartFlow analysis of coronary blood flow using CT angiography: NeXt sTeps) study. J Cardiovasc Comput Tomogr (2013) 0.94
Projected costs and consequences of computed tomography-determined fractional flow reserve. Clin Cardiol (2013) 0.89
The diagnostic performance of CT-derived fractional flow reserve for evaluation of myocardial ischaemia confirmed by invasive fractional flow reserve: a meta-analysis. Clin Radiol (2015) 0.88
Non-invasive functional assessment using computed tomography: when will they be ready for clinical use? Cardiovasc Diagn Ther (2012) 0.85
Cost analysis of non-invasive fractional flow reserve derived from coronary computed tomographic angiography in Japan. Cardiovasc Interv Ther (2014) 0.82
Noninvasive fractional flow reserve derived from coronary computed tomography angiography: integrated anatomical and functional assessment. Future Cardiol (2013) 0.81
RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer. J Clin Oncol (2012) 3.72
Update on myocardial bridging. Circulation (2002) 3.29
Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. J Clin Oncol (2010) 2.72
Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept (2004) 2.56
Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg (2005) 2.35
Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single-institution experience. J Thorac Cardiovasc Surg (2012) 2.08
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. Diabetes Res Clin Pract (2009) 1.90
Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis. Clin Cancer Res (2012) 1.77
Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol (2005) 1.76
Sub-10 nm hexagonal lanthanide-doped NaLuF4 upconversion nanocrystals for sensitive bioimaging in vivo. J Am Chem Soc (2011) 1.51
Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis. Int J Cardiol (2005) 1.43
Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation. EMBO Rep (2008) 1.40
Biodegradable polymer versus permanent polymer sirolimus-eluting stents in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol (2012) 1.39
Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials. Clin Cardiol (2009) 1.34
Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun (2010) 1.29
A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis (2010) 1.25
Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med (2010) 1.23
Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice. J Cardiovasc Pharmacol (2012) 1.22
The use of quantitative real-time reverse transcriptase PCR for 5' and 3' portions of ALK transcripts to detect ALK rearrangements in lung cancers. Clin Cancer Res (2012) 1.21
Integration of cardiac proteome biology and medicine by a specialized knowledgebase. Circ Res (2013) 1.15
Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem (2006) 1.13
Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose. Lung Cancer (2012) 1.12
18F-Labeled magnetic-upconversion nanophosphors via rare-Earth cation-assisted ligand assembly. ACS Nano (2011) 1.11
CXCR6 deficiency ameliorated myocardial ischemia/reperfusion injury by inhibiting infiltration of monocytes and IFN-γ-dependent autophagy. Int J Cardiol (2012) 1.08
Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas. J Thorac Oncol (2014) 1.08
Effects of heart rate and anesthetic timing on high-resolution echocardiographic assessment under isoflurane anesthesia in mice. J Ultrasound Med (2010) 1.08
Telocytes in mice bone marrow: electron microscope evidence. J Cell Mol Med (2014) 1.07
Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trial. Circ Cardiovasc Qual Outcomes (2014) 1.06
microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos. J Lipid Res (2012) 1.05
Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. Eur J Heart Fail (2009) 1.03
Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice. Hypertens Res (2010) 1.03
Naoxintong protects against atherosclerosis through lipid-lowering and inhibiting maturation of dendritic cells in LDL receptor knockout mice fed a high-fat diet. Curr Pharm Des (2013) 1.01
Scanning electron microscope evidence of telocytes in vasculature. J Cell Mol Med (2014) 1.00
Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node. Biomaterials (2011) 1.00
Macrophage polarization in response to wear particles in vitro. Cell Mol Immunol (2013) 0.99
The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials (2009) 0.99
Quantification of allele-specific G-protein beta3 subunit mRNA transcripts in different human cells and tissues by Pyrosequencing. Eur J Hum Genet (2005) 0.99
Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care (2012) 0.98
Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction. Stem Cell Res Ther (2013) 0.98
Meta-analysis of early versus deferred revascularization for non-ST-segment elevation acute coronary syndrome. Am J Cardiol (2011) 0.98
Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy. Hypertension (2011) 0.98
Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. Tohoku J Exp Med (2012) 0.98
Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics. Biomaterials (2009) 0.98
Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin. Cardiovasc Res (2010) 0.97
High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species. Int J Mol Sci (2012) 0.97
Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis. J Am Coll Cardiol (2012) 0.96
Comparison of various niches for endothelial progenitor cell therapy on ischemic myocardial repair: coexistence of host collateralization and Akt-mediated angiogenesis produces a superior microenvironment. Arterioscler Thromb Vasc Biol (2012) 0.96
MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2. Curr Pharm Des (2013) 0.96
High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy. Biochem Biophys Res Commun (2010) 0.95
Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats. Cell Transplant (2005) 0.95
Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction. Int Heart J (2007) 0.95
Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies. Int J Cardiol (2011) 0.94
Comparison of acute recoil between bioabsorbable poly-L-lactic acid XINSORB stent and metallic stent in porcine model. J Biomed Biotechnol (2012) 0.94
MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults. Nutr J (2012) 0.93
Myocardial bridging: a congenital variant as an anatomic risk factor for myocardial infarction? Circulation (2009) 0.92
MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo. Neuro Oncol (2014) 0.92
Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries. Catheter Cardiovasc Interv (2007) 0.92
Efficacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up. Clin Cardiol (2010) 0.91
Comprehensive analysis of oncogenic mutations in lung squamous cell carcinoma with minor glandular component. Chest (2014) 0.91
Early clinical experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv (2014) 0.90
Danhong inhibits oxidized low-density lipoprotein-induced immune maturation of dentritic cells via a peroxisome proliferator activated receptor γ-mediated pathway. J Pharmacol Sci (2012) 0.90
Heat shock transcription factor-1 inhibits H2O2-induced apoptosis via down-regulation of reactive oxygen species in cardiac myocytes. Mol Cell Biochem (2010) 0.90
The role of Th17 cells and regulatory T cells in Coxsackievirus B3-induced myocarditis. Virology (2011) 0.90
Up-regulation of BMP-2 antagonizes TGF-β1/ROCK-enhanced cardiac fibrotic signalling through activation of Smurf1/Smad6 complex. J Cell Mol Med (2012) 0.90
Role of direct estrogen receptor signaling in wear particle-induced osteolysis. Biomaterials (2012) 0.89
Association of Stat3 with HSF1 plays a critical role in G-CSF-induced cardio-protection against ischemia/reperfusion injury. J Mol Cell Cardiol (2012) 0.89
Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice. J Mol Cell Cardiol (2011) 0.89
Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy. Eur J Pharmacol (2011) 0.89
Direct subcutaneous injection of polyethylene particles over the murine calvaria results in dramatic osteolysis. Int Orthop (2013) 0.88
Effects of statin treatment on cardiac function in patients with chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol (2010) 0.88
Usefulness of N-terminal pro-brain natriuretic peptide and C-reactive protein to predict ICU mortality in unselected medical ICU patients: a prospective, observational study. Crit Care (2011) 0.88
Extraction, chemical analysis of Angelica sinensis polysaccharides and antioxidant activity of the polysaccharides in ischemia-reperfusion rats. Int J Biol Macromol (2010) 0.88
Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway. Biochem Biophys Res Commun (2010) 0.88
Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses? Pharmacogenet Genomics (2012) 0.88
A role of myocardial stiffness in cell-based cardiac repair: a hypothesis. J Cell Mol Med (2009) 0.88
Salvianolic acid B suppresses maturation of human monocyte-derived dendritic cells by activating PPARγ. Br J Pharmacol (2011) 0.87
Infarcted myocardium-like stiffness contributes to endothelial progenitor lineage commitment of bone marrow mononuclear cells. J Cell Mol Med (2011) 0.87
Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction. Stem Cell Res Ther (2014) 0.87
Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction. Mol Med (2012) 0.87
Transfer of bone-marrow-derived mesenchymal stem cells influences vascular remodeling and calcification after balloon injury in hyperlipidemic rats. J Biomed Biotechnol (2012) 0.87
Tongxinluo inhibits oxidized low-density lipoprotein-induced maturation of human dendritic cells via activating peroxisome proliferator-activated receptor gamma pathway. J Cardiovasc Pharmacol (2010) 0.86
High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways. Mol Cell Biochem (2012) 0.86
Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model. Cardiovasc Res (2006) 0.86
Relationships between paced QRS duration and left cardiac structures and function. Acta Cardiol (2009) 0.86
The effect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation. Biomaterials (2013) 0.86
Isolation, culture, and identification of amniotic fluid-derived mesenchymal stem cells. Cell Biochem Biophys (2013) 0.86
mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells. J Mol Neurosci (2014) 0.85
Peripheral-blood dendritic cells in men with coronary heart disease. Am J Cardiol (2007) 0.85